picibanil and Histiocytoma--Benign-Fibrous

picibanil has been researched along with Histiocytoma--Benign-Fibrous* in 1 studies

Other Studies

1 other study(ies) available for picibanil and Histiocytoma--Benign-Fibrous

Article	Year
Prolonged partial remission of malignant fibrous histiocytoma in posterior mediastinum by immunotherapy. Chest, 1992, Volume: 101, Issue:4 The case of a 16-year-old female patient with the giant cell type of malignant fibrous histiocytoma (MFH) in the left posterior mediastinum is reported. This is a very unusual site for MFH. Immunotherapy induced a prolonged partial remission lasting 15 months with a marked reduction in tumor size. The usefulness of immunotherapy for MFH needs to be evaluated. Topics: Adolescent; Combined Modality Therapy; Female; Histiocytoma, Benign Fibrous; Humans; Immunotherapy; Interferon alpha-2; Interferon-alpha; Mediastinal Neoplasms; Picibanil; Recombinant Proteins; Remission Induction	1992

Article

Year

Prolonged partial remission of malignant fibrous histiocytoma in posterior mediastinum by immunotherapy.

Chest, 1992, Volume: 101, Issue:4

The case of a 16-year-old female patient with the giant cell type of malignant fibrous histiocytoma (MFH) in the left posterior mediastinum is reported. This is a very unusual site for MFH. Immunotherapy induced a prolonged partial remission lasting 15 months with a marked reduction in tumor size. The usefulness of immunotherapy for MFH needs to be evaluated.

Topics: Adolescent; Combined Modality Therapy; Female; Histiocytoma, Benign Fibrous; Humans; Immunotherapy; Interferon alpha-2; Interferon-alpha; Mediastinal Neoplasms; Picibanil; Recombinant Proteins; Remission Induction

1992